Back to BMRNBioMarin Pharmaceutical Inc. (BMRN)View full pipeline
Active BMN 111: Subcutaneous injection of recommended dose of BMN 111 based on weight-band dosing once daily
Phase 2Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
7 competitors in Achondroplasia
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
sapropterin dihydrochloride, 6R-BH4, tetrahydrobiopterinPhase 3
Phenylketonurias
Cipaglucosidase AlfaPhase 3
Pompe Disease (Late-onset)
MiglustatPhase 3
Pompe Disease (Late-onset)
BMN 110 - WeeklyPhase 3
Mucopolysaccharidosis IV A
Valoctocogene roxaparvovecPhase 3
Hemophilia A With Inhibitor
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts